{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T13:46:41Z","timestamp":1782049601884,"version":"3.54.5"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T00:00:00Z","timestamp":1500940800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1038\/npp.2017.158","type":"journal-article","created":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T11:01:14Z","timestamp":1500980474000},"page":"1001-1009","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Effects of Suvorexant, a Dual Orexin\/Hypocretin Receptor Antagonist, on Impulsive Behavior Associated with Cocaine"],"prefix":"10.1038","volume":"43","author":[{"given":"Taylor A","family":"Gentile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia N","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista L","family":"Connelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugen","family":"Brailoiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W","family":"Muschamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,25]]},"reference":[{"key":"BFnpp2017158_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pbb.2015.04.012","volume":"134","author":"M Alcaraz-Iborra","year":"2015","unstructured":"Alcaraz-Iborra M, Cubero I (2015). Do Orexins contribute to impulsivity-driven binge consumption of rewarding stimulus and transition to drug\/food dependence? Pharmacol Biochem Behav 134: 31\u201334.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp2017158_CR2","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/S0028-3908(99)00141-0","volume":"39","author":"G Arslan","year":"2000","unstructured":"Arslan G, Filipeanu CM, Irenius E, Kull B, Clementi E, Allgaier C et al (2000). P2Y receptors contribute to ATP-induced increases in intracellular calcium in differentiated but not undifferentiated PC12 cells. Neuropharmacology 39: 482\u2013496.","journal-title":"Neuropharmacology"},{"key":"BFnpp2017158_CR3","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nprot.2008.41","volume":"3","author":"A Bari","year":"2008","unstructured":"Bari A, Dalley JW, Robbins TW (2008). The application of the 5-choice serial reaction time task for the assessment of visual attentional processes and impulse control in rats. Nat Protoc 3: 759\u2013767.","journal-title":"Nat Protoc"},{"key":"BFnpp2017158_CR4","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ceca.2015.05.001","volume":"58","author":"JL Barr","year":"2015","unstructured":"Barr JL, Deliu E, Brailoiu GC, Zhao P, Yan G, Abood ME et al (2015). Mechanisms of activation of nucleus accumbens neurons by cocaine via sigma-1 receptor-inositol 1,4,5-trisphosphate-transient receptor potential canonical channel pathways. Cell Calcium 58: 196\u2013207.","journal-title":"Cell Calcium"},{"key":"BFnpp2017158_CR5","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1124\/jpet.114.220392","volume":"352","author":"P Bonaventure","year":"2015","unstructured":"Bonaventure P, Yun S, Johnson PL, Shekhar A, Fitz SD, Shireman BT et al (2015). A selective orexin-1 receptor antagonist attenuates stress-induced hyperarousal without hypnotic effects. J Pharmacol Exp Ther 352: 590\u2013601.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2017158_CR6","doi-asserted-by":"publisher","first-page":"11215","DOI":"10.1523\/JNEUROSCI.6096-08.2009","volume":"29","author":"SL Borgland","year":"2009","unstructured":"Borgland SL, Chang SJ, Bowers MS, Thompson JL, Vittoz N, Floresco SB et al (2009). Orexin A\/hypocretin-1 selectively promotes motivation for positive reinforcers. J Neurosci 29: 11215\u201311225.","journal-title":"J Neurosci"},{"key":"BFnpp2017158_CR7","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.neuron.2006.01.016","volume":"49","author":"SL Borgland","year":"2006","unstructured":"Borgland SL, Taha SA, Sarti F, Fields HL, Bonci A (2006). Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49: 589\u2013601.","journal-title":"Neuron"},{"key":"BFnpp2017158_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00213-009-1596-2","volume":"206","author":"KE Boschen","year":"2009","unstructured":"Boschen KE, Fadel JR, Burk JA (2009). Systemic and intrabasalis administration of the orexin-1 receptor antagonist, SB-334867, disrupts attentional performance in rats. Psychopharmacology (Berl) 206: 205\u2013213.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2017158_CR9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/nm1544","volume":"13","author":"C Brisbare-Roch","year":"2007","unstructured":"Brisbare-Roch C, Dingemanse J, Koberstein R, Hoever P, Aissaoui H, Flores S et al (2007). Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nat Med 13: 150\u2013155.","journal-title":"Nat Med"},{"key":"BFnpp2017158_CR10","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1126\/science.1185778","volume":"329","author":"JW Buckholtz","year":"2010","unstructured":"Buckholtz JW, Treadway MT, Cowan RL, Woodward ND, Li R, Ansari MS et al (2010). Dopaminergic network differences in human impulsivity. Science 329: 532.","journal-title":"Science"},{"key":"BFnpp2017158_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fnbeh.2013.00043","volume":"7","author":"ME Carter","year":"2013","unstructured":"Carter ME, de Lecea L, Adamantidis A (2013). Functional wiring of hypocretin and LC-NE neurons: implications for arousal. Front Behav Neurosci 7: 43.","journal-title":"Front Behav Neurosci"},{"key":"BFnpp2017158_CR12","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.pbb.2007.12.021","volume":"90","author":"J Dalley","year":"2008","unstructured":"Dalley J, Mar A, Economidou D, Robbins T (2008). Neurobehavioral mechanisms of impulsivity: Fronto-striatal systems and functional neurochemistry. Pharmacology Biochemistry and Behavior 90: 250\u2013260.","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"BFnpp2017158_CR13","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1073\/pnas.95.1.322","volume":"95","author":"L de Lecea","year":"1998","unstructured":"de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE et al (1998). The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 95: 322\u2013327.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2017158_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1369-1600.2008.00129.x","volume":"14","author":"H de Wit","year":"2009","unstructured":"de Wit H (2009). Impulsivity as a determinant and consequence of drug use: a review of underlying processes. Addict Biol 14: 22\u201331.","journal-title":"Addict Biol"},{"key":"BFnpp2017158_CR15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00213-010-2048-8","volume":"214","author":"RA Espa\u00f1a","year":"2011","unstructured":"Espa\u00f1a RA, Melchior JR, Roberts DC, Jones SR (2011). Hypocretin 1\/orexin A in the ventral tegmental area enhances dopamine responses to cocaine and promotes cocaine self-administration. Psychopharmacology (Berl) 214: 415\u2013426.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2017158_CR16","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/PL00005481","volume":"146","author":"JL Evenden","year":"1999","unstructured":"Evenden JL (1999). Varieties of impulsivity. Psychopharmacology (Berl) 146: 348\u2013361.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2017158_CR17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0306-4522(02)00017-9","volume":"111","author":"J Fadel","year":"2002","unstructured":"Fadel J, Deutch AY (2002). Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience 111: 379\u2013387.","journal-title":"Neuroscience"},{"issue":"1","key":"BFnpp2017158_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/adb.12507","volume":"23","author":"Taylor A. Gentile","year":"2017","unstructured":"Gentile TA, Simmons SJ, Barker DJ, Shaw JK, Espa\u00f1a RA, Muschamp JW (2017). Suvorexant, an orexin\/hypocretin receptor antagonist, attenuates motivational and hedonic properties of cocaine. Addict Biol (e-pub ahead of print).","journal-title":"Addiction Biology"},{"key":"BFnpp2017158_CR19","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nature04071","volume":"437","author":"GC Harris","year":"2005","unstructured":"Harris GC, Wimmer M, Aston-Jones G (2005). A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437: 556\u2013559.","journal-title":"Nature"},{"key":"BFnpp2017158_CR20","doi-asserted-by":"publisher","first-page":"4497","DOI":"10.1016\/j.bmcl.2003.08.038","volume":"13","author":"M Hirose","year":"2003","unstructured":"Hirose M, Egashira S, Goto Y, Hashihayata T, Ohtake N, Iwaasa H et al (2003). N-acyl 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline: the first orexin-2 receptor selective non-peptidic antagonist. Bioorg Med Chem Lett 13: 4497\u20134499.","journal-title":"Bioorg Med Chem Lett"},{"key":"BFnpp2017158_CR21","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0306-4522(97)00409-0","volume":"83","author":"GE Hunt","year":"1998","unstructured":"Hunt GE, McGregor IS (1998). Rewarding brain stimulation induces only sparse Fos-like immunoreactivity in dopaminergic neurons. Neuroscience 83: 501\u2013515.","journal-title":"Neuroscience"},{"key":"BFnpp2017158_CR22","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1046\/j.0953-816x.2001.01520.x","volume":"13","author":"Y Ishida","year":"2001","unstructured":"Ishida Y, Nakamura M, Ebihara K, Hoshino K, Hashiguchi H, Mitsuyama Y et al (2001). Immunohistochemical characterisation of Fos-positive cells in brainstem monoaminergic nuclei following intracranial self-stimulation of the medial forebrain bundle in the rat. Eur J Neurosci 13: 1600\u20131608.","journal-title":"Eur J Neurosci"},{"key":"BFnpp2017158_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/PL00005483","volume":"146","author":"JD Jentsch","year":"1999","unstructured":"Jentsch JD, Taylor JR (1999). Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl) 146: 373\u2013390.","journal-title":"Psychopharmacology (Berl)"},{"issue":"5","key":"BFnpp2017158_CR24","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.neuron.2009.02.001","volume":"61","author":"Thomas C. Jhou","year":"2009","unstructured":"Jhou TC, Fields HL, Baxter MG, Saper CB, Holland PC (2009a). The rostromedial tegmental nucleus (RMTg), a GABAergic afferent to midbrain dopamine neurons, encodes aversive stimuli and inhibits motor responses. Neuron 61: 786\u2013800..","journal-title":"Neuron"},{"issue":"6","key":"BFnpp2017158_CR25","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/cne.21891","volume":"513","author":"Thomas C. Jhou","year":"2009","unstructured":"Jhou TC, Geisler S, Marinelli M, Degarmo BA, Zahm DS (2009b). The mesopontine rostromedial tegmental nucleus: a structure targeted by the lateral habenula that projects to the ventral tegmental area of Tsai and substantia nigra compacta. J Comp Neurol 513: 566\u2013596..","journal-title":"The Journal of Comparative Neurology"},{"key":"BFnpp2017158_CR26","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1017\/S0033291713002419","volume":"44","author":"RC Kessler","year":"2014","unstructured":"Kessler RC, Adler LA, Berglund P, Green JG, McLaughlin KA, Fayyad J et al (2014). The effects of temporally secondary co-morbid mental disorders on the associations of DSM-IV ADHD with adverse outcomes in the US National Comorbidity Survey Replication Adolescent Supplement (NCS-A). Psychol Med 44: 1779\u20131792.","journal-title":"Psychol Med"},{"key":"BFnpp2017158_CR27","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s40263-014-0179-x","volume":"28","author":"SY Khoo","year":"2014","unstructured":"Khoo SY, Brown RM (2014). Orexin\/hypocretin based pharmacotherapies for the treatment of addiction: DORA or SORA? CNS Drugs 28: 713\u2013730.","journal-title":"CNS Drugs"},{"key":"BFnpp2017158_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1523\/JNEUROSCI.23-01-00007.2003","volume":"23","author":"TM Korotkova","year":"2003","unstructured":"Korotkova TM, Sergeeva OA, Eriksson KS, Haas HL, Brown RE (2003). Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins\/hypocretins. J Neurosci 23: 7\u201311.","journal-title":"J Neurosci"},{"key":"BFnpp2017158_CR29","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.1523\/JNEUROSCI.0719-05.2005","volume":"25","author":"EK Lambe","year":"2005","unstructured":"Lambe EK, Olausson P, Horst NK, Taylor JR, Aghajanian GK (2005). Hypocretin and nicotine excite the same thalamocortical synapses in prefrontal cortex: correlation with improved attention in rat. J Neurosci 25: 5225\u20135229.","journal-title":"J Neurosci"},{"key":"BFnpp2017158_CR30","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1021\/acs.jmedchem.5b00742","volume":"58","author":"MA Letavic","year":"2015","unstructured":"Letavic MA, Bonaventure P, Carruthers NI, Dugovic C, Koudriakova T, Lord B et al (2015). Novel Octahydropyrrolo[3,4-c]pyrroles are Selective Orexin-2 Antagonists: SAR Leading to a Clinical Candidate. J Med Chem 58: 5620\u20135636.","journal-title":"J Med Chem"},{"key":"BFnpp2017158_CR31","doi-asserted-by":"publisher","first-page":"e112440","DOI":"10.1371\/journal.pone.0112440","volume":"9","author":"F Lopez-Torrecillas","year":"2014","unstructured":"Lopez-Torrecillas F, Perales JC, Nieto-Ruiz A, Verdejo-Garcia A (2014). Temperament and impulsivity predictors of smoking cessation outcomes. PLoS ONE 9: e112440.","journal-title":"PLoS ONE"},{"key":"BFnpp2017158_CR32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/cne.1190","volume":"435","author":"JN Marcus","year":"2001","unstructured":"Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, Yanagisawa M et al (2001). Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 435: 6\u201325.","journal-title":"J Comp Neurol"},{"key":"BFnpp2017158_CR33","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1097\/01.wnr.0000132920.12990.b9","volume":"15","author":"LE Martin","year":"2004","unstructured":"Martin LE, Potts GF (2004). Reward sensitivity in impulsivity. Neuroreport 15: 1519\u20131522.","journal-title":"Neuroreport"},{"key":"BFnpp2017158_CR34","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.neuron.2005.04.035","volume":"46","author":"BY Mileykovskiy","year":"2005","unstructured":"Mileykovskiy BY, Kiyashchenko LI, Siegel JM (2005). Behavioral correlates of activity in identified hypocretin\/orexin neurons. Neuron 46: 787\u2013798.","journal-title":"Neuron"},{"key":"BFnpp2017158_CR35","doi-asserted-by":"publisher","first-page":"15585","DOI":"10.1523\/JNEUROSCI.2871-10.2010","volume":"30","author":"DE Moorman","year":"2010","unstructured":"Moorman DE, Aston-Jones G (2010). Orexin\/hypocretin modulates response of ventral tegmental dopamine neurons to prefrontal activation: diurnal influences. J Neurosci 30: 15585\u201315599.","journal-title":"J Neurosci"},{"key":"BFnpp2017158_CR36","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1523\/JNEUROSCI.4121-06.2007","volume":"27","author":"JW Muschamp","year":"2007","unstructured":"Muschamp JW, Dominguez JM, Sato SM, Shen RY, Hull EM (2007). A role for hypocretin (orexin) in male sexual behavior. J Neurosci 27: 2837\u20132845.","journal-title":"J Neurosci"},{"key":"BFnpp2017158_CR37","doi-asserted-by":"publisher","first-page":"E1648","DOI":"10.1073\/pnas.1315542111","volume":"111","author":"JW Muschamp","year":"2014","unstructured":"Muschamp JW, Hollander JA, Thompson JL, Voren G, Hassinger LC, Onvani S et al (2014). Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area. Proc Natl Acad Sci USA 111: E1648\u2013E1655.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2017158_CR38","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/cercor\/10.3.206","volume":"10","author":"D Ongur","year":"2000","unstructured":"Ongur D, Price JL (2000). The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys andhumans. Cereb Cortex 10: 206\u2013219.","journal-title":"Cereb Cortex"},{"key":"BFnpp2017158_CR39","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S0165-0173(97)00039-8","volume":"25","author":"PG Overton","year":"1997","unstructured":"Overton PG, Clark D (1997). Burst firing in midbrain dopaminergic neurons. Brain Res Brain Res Rev 25: 312\u2013334.","journal-title":"Brain Res Brain Res Rev"},{"key":"BFnpp2017158_CR40","doi-asserted-by":"publisher","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","volume":"18","author":"C Peyron","year":"1998","unstructured":"Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG et al (1998). Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18: 9996\u201310015.","journal-title":"J Neurosci"},{"key":"BFnpp2017158_CR41","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/S0960-894X(01)00343-2","volume":"11","author":"RA Porter","year":"2001","unstructured":"Porter RA, Chan WN, Coulton S, Johns A, Hadley MS, Widdowson K et al (2001). 1,3-Biarylureas as selective non-peptide antagonists of the orexin-1 receptor. Bioorg Med Chem Lett 11: 1907\u20131910.","journal-title":"Bioorg Med Chem Lett"},{"key":"BFnpp2017158_CR42","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1021\/cn500246j","volume":"6","author":"CD Prince","year":"2015","unstructured":"Prince CD, Rau AR, Yorgason JT, Espa\u00f1a RA (2015). Hypocretin\/Orexin regulation of dopamine signaling and cocaine self-administration is mediated predominantly by hypocretin receptor 1. ACS Chem Neurosci 6: 138\u2013146.","journal-title":"ACS Chem Neurosci"},{"key":"BFnpp2017158_CR43","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00213-002-1154-7","volume":"163","author":"TW Robbins","year":"2002","unstructured":"Robbins TW (2002). The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl) 163: 362\u2013380.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2017158_CR44","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.bbr.2008.09.021","volume":"196","author":"ES Robinson","year":"2009","unstructured":"Robinson ES, Eagle DM, Economidou D, Theobald DE, Mar AC, Murphy ER et al (2009). Behavioural characterisation of high impulsivity on the 5-choice serial reaction time task: specific deficits in 'waiting' versus 'stopping'. Behav Brain Res 196: 310\u2013316.","journal-title":"Behav Brain Res"},{"key":"BFnpp2017158_CR45","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1046\/j.0953-816x.2001.01518.x","volume":"13","author":"RJ Rodgers","year":"2001","unstructured":"Rodgers RJ, Halford JC, Nunes de Souza RL, Canto de Souza AL, Piper DC, Arch JR et al (2001). SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats. Eur J Neurosci 13: 1444\u20131452.","journal-title":"Eur J Neurosci"},{"key":"BFnpp2017158_CR46","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1021\/acs.jmedchem.5b00832","volume":"59","author":"AJ Roecker","year":"2016","unstructured":"Roecker AJ, Cox CD, Coleman PJ (2016). Orexin receptor antagonists: new therapeutic agents for the treatment of insomnia. J Med Chem 59: 504\u2013530.","journal-title":"J Med Chem"},{"key":"BFnpp2017158_CR47","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nrn3837","volume":"15","author":"T Sakurai","year":"2014","unstructured":"Sakurai T (2014). The role of orexin in motivated behaviours. Nat Rev Neurosci 15: 719\u2013731.","journal-title":"Nat Rev Neurosci"},{"key":"BFnpp2017158_CR48","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","volume":"92","author":"T Sakurai","year":"1998","unstructured":"Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H et al (1998). Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92: 573\u2013585.","journal-title":"Cell"},{"key":"BFnpp2017158_CR49","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1146\/annurev-pharmtox-010510-100528","volume":"51","author":"TE Scammell","year":"2011","unstructured":"Scammell TE, Winrow CJ (2011). Orexin receptors: pharmacology and therapeutic opportunities. Annu Rev Pharmacol Toxicol 51: 243\u2013266.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"BFnpp2017158_CR50","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/sj.bjp.0703953","volume":"132","author":"D Smart","year":"2001","unstructured":"Smart D, Sabido-David C, Brough SJ, Jewitt F, Johns A, Porter RA et al (2001). SB-334867-\u2009A: the first selective orexin-1 receptor antagonist. Br J Pharmacol 132: 1179\u20131182.","journal-title":"Br J Pharmacol"},{"key":"BFnpp2017158_CR51","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1017\/S1121189X00000828","volume":"19","author":"AC Swann","year":"2010","unstructured":"Swann AC (2010). Mechanisms of impulsivity in bipolar disorder and related illness. Epidemiol Psichiatr Soc 19: 120\u2013130.","journal-title":"Epidemiol Psichiatr Soc"},{"key":"BFnpp2017158_CR52","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/bjc.12091","volume":"54","author":"G Vall","year":"2015","unstructured":"Vall G, Gutierrez F, Peri JM, Garriz M, Ferraz L, Bailles E et al (2015). Seven basic dimensions of personality pathology and their clinical consequences: are all personalities equally harmful? Br J Clin Psychol 54: 450\u2013468.","journal-title":"Br J Clin Psychol"},{"key":"BFnpp2017158_CR53","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S0896-6273(03)00330-1","volume":"38","author":"JT Willie","year":"2003","unstructured":"Willie JT, Chemelli RM, Sinton CM, Tokita S, Williams SC, Kisanuki YY et al (2003). Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes. Neuron 38: 715\u2013730.","journal-title":"Neuron"},{"key":"BFnpp2017158_CR54","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cpr.2006.01.001","volume":"26","author":"CA Winstanley","year":"2006","unstructured":"Winstanley CA, Eagle DM, Robbins TW (2006). Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clin Psychol Rev 26: 379\u2013395.","journal-title":"Clin Psychol Rev"},{"key":"BFnpp2017158_CR55","doi-asserted-by":"publisher","first-page":"11075","DOI":"10.1523\/JNEUROSCI.3542-07.2007","volume":"27","author":"H Zheng","year":"2007","unstructured":"Zheng H, Patterson LM, Berthoud HR (2007). Orexin signaling in the ventral tegmental area is required for high-fat appetite induced by opioid stimulation of the nucleus accumbens. J Neurosci 27: 11075\u201311082.","journal-title":"J Neurosci"},{"key":"BFnpp2017158_CR56","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1254\/jphs.92.259","volume":"92","author":"Y Zhu","year":"2003","unstructured":"Zhu Y, Miwa Y, Yamanaka A, Yada T, Shibahara M, Abe Y et al (2003). Orexin receptor type-1 couples exclusively to pertussis toxin-insensitive G-proteins, while orexin receptor type-2 couples to both pertussis toxin-sensitive and -insensitive G-proteins. J Pharmacol Sci 92: 259\u2013266.","journal-title":"J Pharmacol Sci"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2017158.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2017158","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/npp.2017.158","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/npp2017158.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:57:51Z","timestamp":1684454271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2017158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,25]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["BFnpp2017158"],"URL":"https:\/\/doi.org\/10.1038\/npp.2017.158","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,25]]},"assertion":[{"value":"28 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}